QuidelOrtho and BÜHLMANN Laboratories AG announced the availability of the fCAL® turbo and fPELA® turbo assays on VITROS™ Systems, enabling rapid and non-invasive diagnosis of IBD and pancreatic insufficiency.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
BÜHLMANN Laboratories AG announces a worldwide collaboration with Beckman Coulter for the distribution of fCAL® turbo and fPELA® turbo assays. This partnership enables seamless integration of fecal inflammation and digestion marker testing into automated laboratory workflows.
Discover the latest advancements from the EAACI 2023 Congress in Hamburg, featuring three insightful posters on the Basophil Activation Test. Topics include validation studies, technical cut-offs, and automated gating strategies.
From gastroenterology to neuroimmunology, read the newest developments from BÜHLMANN in our posters presented at the WorldLab 2024!
Social Links